Cataract Surgery Devices Market in Asia Pacific is expected to register a CAGR of 6.1% during the forecast period (2018 - 2024) - KBV Research

Feb-19 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report Asia Pacific Cataract Surgery Devices Market, published by KBV research, the Asia Pacific Cataract Surgery Devices Market would witness market growth of 6.1% CAGR during the forecast period (2018 – 2024).

The Japan market would dominate the Asia Pacific Equipment Market by Country 2024; thereby, growing at a CAGR of 4.3 % during the forecast period. The China market is expected to witness a CAGR of 7.5% during (2018 - 2024). Additionally, The India market is expected to witness a CAGR of 7.6% during (2018 - 2024).

The Hospitals market dominated the Asia Pacific Cataract Surgery Devices Market by End User 2017, thereby, achieving a market value of $1,125.3 million by 2024. The Ambulatory Surgery Centers (ASCs) market is expected to witness a CAGR of 7.2% during (2018 - 2024).

The Ophthalmic Viscoelastic Device (OVD) market dominated the South Korea Cataract Surgery Devices Market by Product 2017, achieving a market value of $106.3 million by 2024. The Intraocular Lens (IOL) market is expected to witness a CAGR of 7.2% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/asia-pacific-cataract-surgery-devices-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Novartis Ag, Abbott Laboratories, Carl Zeiss Meditec Ag, Essilor International S.A, Johnson & Johnson, Metall Zug AG, Topcon Corporation, Nidek Co., Ltd, Valeant Pharmaceuticals International, Inc. and Ziemer Ophthalmic Systems Ag.

Asia Pacific Cataract Surgery Devices Market Segmentation

By Type